Ian Taylor
Förmögenhet: 1 M $ per 2026-05-31
Förmögenhet: 1 M $ per 2026-05-31
Ian Taylor worked at Pfizer Inc. from 2007 to 2016 as Senior Director-Translational Oncology.
Dr. Taylor worked at Bayer HealthCare as Vice President-Cancer Biology.
Dr. Taylor worked at Arvinas, Inc. from 2016 to 2025 as President-Research & Development from 2024 to 2025.
Dr. Taylor earned a doctorate from Harvard University and completed undergraduate studies at Bowdoin College.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ARVINAS, INC. 0,22 % | 2026-03-31 | 138 876 ( 0,22 % ) | 1 M $ | 2026-05-31 |
| Företag | Position | Slut |
|---|---|---|
| ARVINAS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2025-06-06 |
| PFIZER INC. | Företagsledare/Principal | 2016-05-01 |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Arvinas, Inc.
Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån